Investors / United Kingdom / Oxford Science Enterprises
Oxford Science Enterprises
Venture capital · Oxford, United Kingdom · Europe
Oxford Science Enterprises is an independent investment company and venture builder with a partnership with the University of Oxford. It finds, funds and builds companies from Oxford research, working with researchers and co-investors to create and scale ventures.
Invests inHealthcare & BiotechAI & Machine Learning
In its own wordsdeep techlife scienceshealthtechquantum computingventure buildinguniversity spinouts
Your fit with Oxford Science Enterprises
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsOxford Science Enterprises lists 75 checked portfolio companies on its own site and is named in 20 funding rounds, 6 of them as lead. Its most frequent entry is Seed, 35% of the companies with a known first round. Its largest themes are Healthcare & Biotech (38%), AI & Machine Learning (22%) and Industrial & Manufacturing (14%). 78% of its companies are based in United Kingdom. It invests most often alongside Oxford Investment Consultants, Future Planet Capital and Parkwalk Advisors.
Counts come from funding rounds that name Oxford Science Enterprises, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not Oxford Science Enterprises' whole history. Rounds on record name 20 companies; its own site lists 75. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundShow as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 35% |
| Series A | 35% |
| Series B | 5% |
| Growth | 25% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 1 | 0 |
| '25 | 0 | 0 |
| '26 | 19 | 6 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 92th | 75 companies |
| Recent activity | 98th | 19 rounds in 12 months |
| Early stage | 64th | 35% of entries at pre-seed or seed |
| Evidence | 93th | 23% of companies confirmed by a round |
| Sector focus | 70th | 38% in its largest sector |
| Reach | 70th | 4 countries |
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 38% | 15% |
| AI & Machine Learning | 22% | 18% |
| Industrial & Manufacturing | 14% | 7% |
| Education | 10% | 7% |
| Cybersecurity | 5% | 4% |
| Enterprise Software | 3% | 8% |
| Space & Defense | 3% | 3% |
| Robotics & Hardware | 2% | 1% |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| Oxford Investment Consultants | 11 |
| Future Planet Capital | 7 |
| Parkwalk Advisors | 6 |
| British Business Bank | 5 |
| BGF | 3 |
| Creative Destruction Lab | 3 |
| Forbion | 3 |
| Octopus Ventures | 3 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers7397%
- No longer answers00%
- Points to another company23%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Co-investor network
who it backs companies with, and who they back togetherAll co-investors or Compare portfolios with Oxford Investment Consultants
Compare Oxford Science Enterprises head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with Oxford Science Enterprises| Date | Company | Stage |
|---|---|---|
| 10 Nov 2026 | Series A | |
| 5 Nov 2026 | Series A | |
| 5 Nov 2026 | Series A | |
| 15 Oct 2026 | Series C+ | |
| 6 Oct 2026 | Series A Led | |
| 5 Oct 2026 | Series A | |
| 15 Sept 2026 | Series A | |
| 9 Sept 2026 | Seed Led |
Round details for Oxford Science Enterprises
Amounts, full round histories and every co-investor in Oxford Science Enterprises' rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
75 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Alethio Therapeutics is developing therapies to improve outcomes for patients with myeloproliferative neoplasms, a group of blood cancers. | Healthcare & Biotech | Nov 2026Series A | Page + round | |
| Allos uses advanced AI modeling to reduce experimentation, spend, and time to market for drug formulation and development | Healthcare & Biotech | Portfolio page | ||
| Alloyed designs and manufactures metal components using digital technologies and 3D printing | AI & Machine LearningAI & Machine Learning | Portfolio page | ||
| The company transforms rare respiratory disease outcomes using inhaled gene therapy | Healthcare & Biotech | Portfolio page | ||
| Amber Therapeutics is developing the first adaptive neuromodulation therapy to treat women suffering with mixed urinary incontinence | Healthcare & Biotech | Portfolio page | ||
| Applied Atomics develops, builds, and operates medium modular nuclear fission plants at customer sites | EducationIndustrial & Manufacturing | Portfolio page | ||
| The company connects networks in space with networks on the ground using laser communication systems. | Space & DefenseCybersecurity | Portfolio page | ||
| Ascension sources metals from volcanic rock using a process that respects the environment and communities. | Industrial & ManufacturingAI & Machine Learning | Apr 2026Seed | Page + round | |
| Barinthus Biotherapeutics is a clinical-stage biopharmaceutical company developing novel immunotherapies designed to treat immunology and inflammatory indications by guiding T cells to overcome autoimmunity and inflammatory diseases. | Healthcare & Biotech | Portfolio page | ||
| Beacon Therapeutics is a biotechnology company that develops gene therapies for ocular diseases | Healthcare & Biotech | Jan 2026Series C+ | Page + round | |
| BibliU partners with colleges and universities to deliver a fully integrated campus store experience—combining affordable, Day 1 access to course materials with hybrid physical and online retail. | Education | Portfolio page | ||
| Caristo Diagnostics develops and provides technology for cardiac disease diagnosis and prevention, including the CaRi-Heart technology to measure coronary inflammation and assess cardiovascular mortality risk. | Healthcare & Biotech | Portfolio page | ||
| Dark Blue Therapeutics is reimagining the discovery ecosystem to deliver precision medicines for patients with the highest need. | Healthcare & Biotech | Portfolio page | ||
| Densix creates next-generation power converters with world-leading power density | Industrial & ManufacturingEducation | Mar 2026Seed | Page + round | |
| Diffblue creates comprehensive and high-quality test coverage with developer intervention using AI coding tools | AI & Machine LearningEnterprise Software | Portfolio page | ||
| The company is developing disease-modifying therapeutics to restore endo-lysosomal function and abrogate neurodegeneration in Parkinson’s disease and other dementias. | Healthcare & Biotech | Portfolio page | ||
| Evolito develops and manufactures electric machines for type-certifiable applications and volume manufacture. | AI & Machine LearningAI & Machine Learning | Portfolio page | ||
| Portfolio page | ||||
| First Light Fusion is a company that aims to achieve commercial fusion energy using its FLARE fusion fuel system | Industrial & ManufacturingSpace & Defense | Portfolio page | ||
| FluoRok develops technology for safer and more efficient fluorochemical manufacturing | Industrial & Manufacturing | Nov 2026Series A | Page + round |
About this data
site last read 8 Nov 2026- Site
- oxfordscienceenterprises.com
- Last read
- 8 Nov 2026
- Watching since
- 6 Nov 2026
- Rounds since
- 20 Jun 2024
- Companies checked
- 75
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Oxford Science Enterprises' profile as data
Pull Oxford Science Enterprises' portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/oxfordscienceenterprises.com
# also
GET /v1/firms/oxfordscienceenterprises.com/portfolio
GET /v1/firms/oxfordscienceenterprises.com/coinvestors
GET /v1/firms/oxfordscienceenterprises.com/news